The treatment of acute coronary syndromes (ACS) and percutaneous coronary intervention
(PCI) encompasses a wide spectrum of pharmacological strategies ranging from clot lysis in …

The proaggregatory and antiaggregatory factors of the hemostatic system are normally finely
balanced, opposing mechanisms. To protect against vascular damage and the risk of …

Antithrombotic therapy is a major cornerstone in the treatment for acute coronary syndromes,
as thrombus formation upon a plaque rupture or an erosion plays a pivotal role in non-ST …

Advances in the management of patients with acute coronary syndromes (ACS), specifically,
the use of combined pharmacotherapy with antithrombotic and antiplatelet therapies and …

Antithrombotic therapy, including antiplatelet and antithrombin agents, effectively reduces
the risk of ischemic events in patients with acute coronary syndromes (ACS) and those …

Background The development of newer and more potent antithrombotic agents and
strategies has markedly reduced cardiovascular mortality and ischemic complications in …

Acute coronary syndromes (ACS), including unstable angina, non-ST elevation myocardial
infarction, and ST-elevation myocardial infarction, are the most commonly encountered …

Legend holds that Tobias Hobson, the first Englishman to rent horses for hackney use,
offered potential customers one of two choices: take the horse nearest the door of his …

Although the use of oral and intravenous antiplatelet and antithrombin therapy in the acute
and chronic settings of percutaneous coronary intervention (PCI), acute coronary syndromes …

The formation of an intravascular thrombus underlies the clinical symptoms associated with
acute coronary syndromes (ACS). Plaque rupture signals the recruitment and activation of …